Intrapleural Fibrinolytic Therapy versus Early Medical Thoracoscopy for Treatment of Pleural Infection. Randomized Controlled Clinical Trial
- 1 August 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 17 (8) , 958-964
Abstract
Rationale: Pleural infection is frequently encountered in clinical practice and is associated with high morbidity and mortality. Limited evidence exists regarding the optimal treatment. Although both early medical thoracoscopy (MT) and tube thoracostomy with intrapleural instillation of tissue plasminogen activator and human recombinant deoxyribonuclease are acceptable treatments for patients with complicated pleural infection, there is a lack of comparative data for these modes of management. Objectives: The aim of this study was to compare the safety and efficacy of early MT versus intrapleural fibrinolytic therapy (IPFT) in selected patients with multiloculated pleural infection and empyema. Methods: This was a prospective multicenter, randomized controlled trial involving patients who underwent MT or IPFT for pleural infection. The primary outcome was the length of hospital stay after either intervention. Secondary outcomes included the total length of hospital stay, treatment failure, 30-day mortality, and adverse events. Results: Thirty-two patients with pleural infection were included in the study. The median length of stay after an intervention was 4 days in the IPFT arm and 2 days in the MT arm (P = 0.026). The total length of hospital stay was 6 days in the IPFT arm and 3.5 days in MT arm (P = 0.12). There was no difference in treatment failure, mortality, or adverse events between the treatment groups, and no serious complications related to either intervention were recorded. Conclusions: When used early in the course of a complicated parapneumonic effusion or empyema, MT is safe and might shorten hospital stays for selected patients as compared with IPFT therapy. A multicenter trial with a larger sample size is needed to confirm these findings. Clinical trial registered with ClinicalTrials.gov (NCT02973139).Keywords
This publication has 31 references indexed in Scilit:
- Incidence, Length of Stay, and Prognosis of Hospitalized Patients With Pleural EmpyemaChest, 2014
- Is Medical Thoracoscopy Efficient in the Management of Multiloculated and Organized Thoracic Empyema?Respiration, 2012
- Intrapleural Use of Tissue Plasminogen Activator and DNase in Pleural InfectionNew England Journal of Medicine, 2011
- Emergence of parapneumonic empyema in the USAThorax, 2011
- Management of pleural infection in adults: British Thoracic Society pleural disease guideline 2010Thorax, 2010
- Treatment of Sonographically Stratified Multiloculated Thoracic Empyema by Medical ThoracoscopyChest, 2005
- U.K. Controlled Trial of Intrapleural Streptokinase for Pleural InfectionNew England Journal of Medicine, 2005
- Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusionsClinical Science, 2003
- Predictors of Outcome and Long-term Survival in Patients with Pleural InfectionAmerican Journal of Respiratory and Critical Care Medicine, 1999
- The clinical course and management of thoracic empyemaQJM: An International Journal of Medicine, 1996